Life Technologies to grow PCR offering with BioTrove buy
This article was originally published in Clinica
Biotech firm Life Technologies (Carlsbad, California) is to strengthen its portfolio of PCR genotyping products by purchasing BioTrove, a gene expression specialist. The deal will provide Life Technologies with BioTrove’s OpenArray platform, which it describes as a “high-throughput gene expression and genotyping analysis system based on a flexible array format that enables researchers to perform more than 3,000 PCR genotyping or qPCR gene expression assays at a time”. Life Technologies’ Applied Biosystems subsidiary previously commercialised the OpenArray system after collaborating with BioTrove in 2007. Financial terms of the acquisition were not disclosed. However, Life Technologies did say that it expects the deal to not have a material impact on its financials in fiscal 2009.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals